Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Text Size
906 studies found for:    "Hypercholesterolemia"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
"Hypercholesterolemia" (906 records)
Need help? See Downloading Content for Analysis
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
2 Completed Polish Survey on the Efficacy of the Hypercholesterolemia Treatment
Condition: Hypercholesterolemia
Intervention:
3 Terminated Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: Placebo
4 Terminated Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: 25 mg/day AVE5530;   Drug: 50 mg/day AVE5530;   Drug: placebo
5 Completed A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)
Condition: Hypercholesterolemia
Interventions: Drug: MK0653A, ezetimibe (+) simvastatin;   Drug: Comparators: simvastatin and ezetimibe
6 Completed An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)
Condition: Hypercholesterolemia
Intervention: Drug: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 14 weeks
7 Terminated Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: atorvastatin;   Drug: placebo
8 Completed
Has Results 		A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)
Condition: Hypercholesterolemia
Interventions: Drug: ezetimibe;   Drug: Comparator: placebo
9 Completed An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
10 Unknown † Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: vitamin D3 tablets;   Drug: placebo tablets
11 Completed Pan-European Survey on the Under Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
12 Completed Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
13 Completed Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States
Condition: Hypercholesterolemia
Intervention:
14 Completed
Has Results 		Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)
Condition: Primary Hypercholesterolemia
Interventions: Drug: ezetimibe;   Drug: Placebo
15 Completed Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
16 Completed A Study on the Effects of Soy Protein on Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Soy protein; 25 grams/day;   Dietary Supplement: Control protein
17 Completed Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia
Condition: Undertreatment of Hypercholesterolaemia
Intervention:
18 Completed A Study of LY3015014 in Participants With High Cholesterol
Condition: Hypercholesterolemia
Interventions: Drug: LY3015014;   Drug: Placebo
19 Completed Systematic Management of High Cholesterol Utilizing Computer Monitoring
Condition: Hypercholesterolemia
Interventions: Drug: Simvastin;   Procedure: Computer-based decision support technology
20 Completed Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: LGT209;   Drug: Placebo
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Study has passed its completion date and status has not been verified in more than two years.